Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019045 (
hemoglobinopathies
)
2,704
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
There is adequate evidence for screening neonates for
hemoglobinopathies
, congenital hypothyroidism, phenylketonuria (strength of recommendation [
SOR
]: A), and cystic fibrosis (
SOR
: B). Vision screening should be done for those younger than age 5 years (
SOR
: B). High-risk children should be tested for tuberculosis (TB) (
SOR
: B) and lead toxicity (
SOR
: B). Few data exist to guide frequency and timing of these screening tests, so the following timing recommendations are based on consensus opinion (
SOR
: C): test for visual acuity yearly starting at age 3 years; test for TB and lead once between the ages of 9 and 12 months, and repeat for high risk or exposure.
...
PMID:Clinical inquiries. What are appropriate screening tests for infants and children? 1694 66
